Hongxia Wei
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Antifungal resistance and susceptibility
- Neurology top 10%
- Long-Term Effects of COVID-19
Papers in
- Epidemiology 15
- Fungal Infections and Studies 8
- Cytomegalovirus and herpesvirus research 4
-
- HIV/AIDS Research and Interventions 6
- HIV/AIDS drug development and treatment 6
- Antifungal resistance and susceptibility 3
- COVID-19 Clinical Research Studies 3
- Co-authors
- Dayong Cai (1 shared paper)Liming Zhi (1 shared paper)Xinjuan Sun (1 shared paper)Yuying Qiu (1 shared paper)Hui Liao (1 shared paper)Tianyuan Wang (1 shared paper)Zhihong Zhang (1 shared paper)Jinan Chen (1 shared paper)
- Journals
- Heliyon (2 papers)Annals of Clinical Microbiology and Antimicrobials (2 papers)Drug Discoveries & Therapeutics (2 papers)Frontiers in Public Health (2 papers)Apmis (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Hongxia Wei
32 papers receiving 722 citations
Peers
Comparison fields: 5 of 94
- Infectious Diseases 368
- Neurology 156
- Microbiology 6
- Molecular Medicine 30
- Epidemiology 154
Countries citing papers authored by Hongxia Wei
This map shows the geographic impact of Hongxia Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxia Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxia Wei more than expected).
Fields of papers citing papers by Hongxia Wei
This network shows the impact of papers produced by Hongxia Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxia Wei. The network helps show where Hongxia Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Hongxia Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 357 | |
| 2 | 2018 | 54 | |
| 3 | 2019 | 53 | |
| 4 | 2020 | 36 | |
| 5 | 2014 | 30 | |
| 6 | 2020 | 30 | |
| 7 | 2017 | 26 | |
| 8 | 2022 | 17 | |
| 9 | 2022 | 15 | |
| 10 | 2020 | 11 | |
| 11 | 2016 | 11 | |
| 12 | 2019 | 10 | |
| 13 | 2013 | 10 | |
| 14 | 2012 | 10 | |
| 15 | 2020 | 8 | |
| 16 | 2022 | 7 | |
| 17 | 2020 | 7 | |
| 18 | 2025 | 6 | |
| 19 | [Effect of compound glycyrrhizin on peripheral T-lymphocyte subset in AIDS patients]. | 2006 | 6 |
| 20 | 2021 | 4 |
About Hongxia Wei
Hongxia Wei is a scholar working on Epidemiology, Infectious Diseases, Virology, Neurology and Molecular Biology, having authored 37 papers that have together received 740 indexed citations. Recurring topics across this work include Fungal Infections and Studies (8 papers), HIV/AIDS Research and Interventions (6 papers), HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (5 papers), Cytomegalovirus and herpesvirus research (4 papers), Long-Term Effects of COVID-19 (4 papers), Antifungal resistance and susceptibility (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Infectious Diseases (368 citations), Neurology (156 citations), Microbiology (6 citations), Molecular Medicine (30 citations) and Epidemiology (154 citations). Hongxia Wei has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Dayong Cai, Liming Zhi, Xinjuan Sun, Yuying Qiu, Hui Liao, Tianyuan Wang, Zhihong Zhang, Jinan Chen, Aiping Wang and Zhiwei Hu. Their work appears in journals such as Heliyon, Annals of Clinical Microbiology and Antimicrobials, Drug Discoveries & Therapeutics, Frontiers in Public Health and Apmis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.